And this finding is similar to previous studies that increased cell surface expression of TF was associated with higher procoagulant activity in malignancies and higher circulating levels in vivo [57, 58], which was also shown in breast and ovarian cancer patients [59, 60]. The gene discussed is TF; the disease is ovarian cancer.